BURLINGTON, Mass. & NEW YORK--(BUSINESS WIRE)-- Butterfly Network Inc. (“Butterfly,” “the Company”) (NYSE: BFLY), a digital health company transforming care with portable semiconductor-based ultrasound technology and intuitive software, announced the commercial launch of its third-generation handheld point-of-care ultrasound (POCUS) system, Butterfly iQ3™ in Europe. Butterfly iQ3 is powered by the Company’s most advanced semiconductor chip, enabling unparalleled image quality and new advanced 3D capabilities: iQ Slice™ and iQ Fan™.
Butterfly iQ3 is CE marked, certified under European Union Medical Device Regulation (EU MDR), and it is fully compliant with the Restriction of Hazardous Substances (RoHS) Directive without relying on the lead exemption that traditional piezoelectric crystal-based ultrasound devices require due to hazardous levels of lead in their transducers.
Joseph DeVivo, Butterfly Network’s President, Chief Executive Officer, and Board Chairman, commented, "After witnessing the enthusiastic uptake of Butterfly iQ3 in the United States and Canada over the past few months, we’ve been eager to receive the regulatory approval to introduce this high-performance device in Europe. We’re confident that the enhanced image quality and advanced features of Butterfly iQ3 will bring significant value to healthcare providers across Europe, supporting them in delivering quality patient care. Our mission to democratize ultrasound continues, and we are excited to continue seeing the promise of Butterfly iQ3 benefit new regions."
Butterfly iQ3 brings best-in-class high-resolution image quality with twice the processing power compared to Butterfly iQ+ and a novel “no focus” rubber lens, enabling providers to intuitively identify anatomy, observe small structures, and ultimately make more confident diagnostic decisions. In a blind survey distributed by third-party vendor Intellisurvey, 475 clinicians across more than eight specialties compared Butterfly iQ3 images to GE Vscan Air™ CL, with the majority across all categories ranking iQ3’s overall image quality better than that of GE Vscan Air™ CL.*
"I was privileged to have a preview of the Butterfly iQ3 and am thoroughly impressed with the improvements so far and the positive impact they will have on patient care in my practice," said Dr. Zack Ferguson, Specialty Registrar in Acute Internal Medicine at West Middlesex Hospital. "Notably, the enhancement in echo image quality on the new Butterfly iQ3 represents a significant advancement from the prior iQ models, and the biplane mode for cannulation has already proven beneficial in managing patients with challenging IV access."
Launching on Butterfly iQ3 are two new advanced 3D imaging capabilities designed to make image capturing easier: iQ Slice and iQ Fan. These tools join Butterfly’s existing robust feature list of over 20 anatomical presets, six imaging modes (B-Mode, M-Mode, Color Doppler, Power Doppler, Pulsed-Wave Doppler, and Biplane Imaging™), and a collection of artificial intelligence (AI) and advanced imaging tools (e.g., Auto Bladder Volume Capture, Auto B-Line Counter, NeedleViz™, and a rich set of Calculation tools).
The new shape of ultrasound: enhanced comfort and efficiency.
Butterfly iQ3 features a new user-centric ergonomic design that is smaller, lighter, and better distributed, and with even stronger battery:
Butterfly Network’s Chief Medical Officer, John Martin, MD, concludes, “'We are pleased that our customer response to Butterfly iQ3 matches our enthusiasm for this remarkable advance. Our customers asked for better resolution, and we delivered with exceptional image quality, as well as a smaller more ergonomic design, and improved performance. iQ3’s immediate boot-up, long run time, and fit-in-hand comfort ensure it is always ready for use. We are proud to bring Europe our newest solution that meets the standards of advanced users while remaining accessible for those new to ultrasound, all at an unmatched value.”
As of today, September 4, 2024, Butterfly iQ3 is now commercially available to healthcare providers in Austria, Belgium, Denmark, Finland, France, Germany, Ireland, Italy, the Netherlands, Norway, Poland, Portugal, Spain, Sweden, Switzerland, and the UK. To learn more about Butterfly iQ3, pricing, trade-in offers for existing customers, or to purchase, visit your local website: https://www.butterflynetwork.com/choose-your-country
Founded by Dr. Jonathan Rothberg in 2011, Butterfly Network is a digital health company with a mission to democratize medical imaging by making high-quality ultrasound affordable, easy-to-use, globally accessible, and intelligently connected, including for the 4.7 billion people around the world lacking access to ultrasound. Butterfly created the world's first handheld single-probe whole-body ultrasound system using semiconductor technology, Butterfly iQ. The company has continued to innovate, leveraging the benefits of Moore’s Law to launch its second-generation Butterfly iQ+ in 2020 and third-generation iQ3 in 2024—each with increased processing power and performance enhancements. The disruptive technology has been recognized by TIME’s Best Inventions, Fast Company’s World Changing Ideas, CNBC Disruptor 50, and MedTech Breakthrough Awards, among other accolades. With its proprietary Ultrasound-on-Chip™ technology, intelligent software, and educational offerings, Butterfly is paving the way to mass adoption of ultrasound for earlier detection and remote management of health conditions around the world. Butterfly devices are commercially available to trained healthcare practitioners in areas including but not limited to parts of Africa, Asia, Australia, Europe, the Middle East, North America, and South America; to learn more about available countries, visit: butterflynetwork.com/choose-your-country .
*Internal data available upon request.
Butterfly Media:
Liz Learned
Head of Corporate Communications
media@butterflynetwork.com
Butterfly Investors:
Heather Getz
Chief Financial and Operations Officer
investors@butterflynetwork.com
Source: Butterfly Network Inc.